Blink Health offers free medications on various prescriptionsBlink Health is offering new patients more than 4,000 medications for free. Armas introduces generic TarcevaErlotinib has a market value of approximately $150 million annually, according to sales data. Amneal launches 3 generics Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension). Lupin launches generic Westcort cream Hydrocortisone valerate cream 0.2% had a market value of roughly $11.5 million, according to IQVIA September 2019 data. Breckenridge gets FDA clearance for generic Exelon Patch The Exelon Patch and its generics had a market value of $161 million for the 12 months ended Sept. 30, 2019. Mylan, Biocon launch Herceptin biosimilar Ogivri Mylan's Ogivri is available in 420 mg multidose vials and 150 mg single-dose vials. FDA approves Glenmark’s generic Glumetza extended-release tablets Branded Glumetza saw sales of $226.7 million in the year ended September 2019, according to IQVIA data. Teva launches generic Jadenu tablets The generic of Novartis’ branded product will be available in dosage strengths of 90- and 360-mg. STI Pharma intros generic Bicnu STI Pharma is launching its first oncology injectable with the introduction of its generic of Bicnu (carmustine for injection) Aurobindo nabs 2 honors at Global Generics and Biosimilars Awards Aurobindo took home the Company of the Year and Acquisition of the Year awards at the event, which was held Nov. 5 in Frankfurt, Germany. First Previous 154 155 156 157 158 Next Last